Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)

Chiun Hsu, Bang Bin Chen, Chien Hung Chen, Ming Chih Ho, Jason Chia Hsien Cheng, Norihiro Kokudo, Takamichi Murakami, Winnie Yeo, Jinsil Seong, Ji Dong Jia, Kwan Hyub Han, Ann Lii Cheng

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized.

Original languageEnglish
Pages (from-to)96-105
Number of pages10
JournalLiver Cancer
Volume4
Issue number2
DOIs
Publication statusPublished - 2015 Apr 27

Fingerprint

Liver Neoplasms
Consensus
Hepatocellular Carcinoma
Clinical Trials
Committee Membership
Taiwan
Patient Care
Radiotherapy
Recurrence
Drug Therapy
Therapeutics
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Oncology

Cite this

Hsu, C., Chen, B. B., Chen, C. H., Ho, M. C., Cheng, J. C. H., Kokudo, N., ... Cheng, A. L. (2015). Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014). Liver Cancer, 4(2), 96-105. https://doi.org/10.1159/000367732
Hsu, Chiun ; Chen, Bang Bin ; Chen, Chien Hung ; Ho, Ming Chih ; Cheng, Jason Chia Hsien ; Kokudo, Norihiro ; Murakami, Takamichi ; Yeo, Winnie ; Seong, Jinsil ; Jia, Ji Dong ; Han, Kwan Hyub ; Cheng, Ann Lii. / Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014). In: Liver Cancer. 2015 ; Vol. 4, No. 2. pp. 96-105.
@article{6a584220e2914a2f9d8e7e00963a1ff7,
title = "Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)",
abstract = "A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized.",
author = "Chiun Hsu and Chen, {Bang Bin} and Chen, {Chien Hung} and Ho, {Ming Chih} and Cheng, {Jason Chia Hsien} and Norihiro Kokudo and Takamichi Murakami and Winnie Yeo and Jinsil Seong and Jia, {Ji Dong} and Han, {Kwan Hyub} and Cheng, {Ann Lii}",
year = "2015",
month = "4",
day = "27",
doi = "10.1159/000367732",
language = "English",
volume = "4",
pages = "96--105",
journal = "Liver Cancer",
issn = "2235-1795",
publisher = "S. Karger AG",
number = "2",

}

Hsu, C, Chen, BB, Chen, CH, Ho, MC, Cheng, JCH, Kokudo, N, Murakami, T, Yeo, W, Seong, J, Jia, JD, Han, KH & Cheng, AL 2015, 'Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)', Liver Cancer, vol. 4, no. 2, pp. 96-105. https://doi.org/10.1159/000367732

Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014). / Hsu, Chiun; Chen, Bang Bin; Chen, Chien Hung; Ho, Ming Chih; Cheng, Jason Chia Hsien; Kokudo, Norihiro; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Jia, Ji Dong; Han, Kwan Hyub; Cheng, Ann Lii.

In: Liver Cancer, Vol. 4, No. 2, 27.04.2015, p. 96-105.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)

AU - Hsu, Chiun

AU - Chen, Bang Bin

AU - Chen, Chien Hung

AU - Ho, Ming Chih

AU - Cheng, Jason Chia Hsien

AU - Kokudo, Norihiro

AU - Murakami, Takamichi

AU - Yeo, Winnie

AU - Seong, Jinsil

AU - Jia, Ji Dong

AU - Han, Kwan Hyub

AU - Cheng, Ann Lii

PY - 2015/4/27

Y1 - 2015/4/27

N2 - A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized.

AB - A key mission of the Asia-Pacific Primary Liver Cancer Expert (APPLE) Association is to ensure a coherent view for management of hepatocellular carcinoma (HCC) and to advance new treatment for this difficult disease. At the 5th APPLE meeting, held in July 2014 in Taipei, Taiwan, an APPLE consensus development program was established to facilitate discussion among experts in the Asia-Pacific region on pertinent issues for HCC management, including (1) surgery for intermediate/advanced-stage disease, (2) prevention of HCC recurrence after curative treatment, (3) optimizing imaging diagnosis, (4) radiotherapy: current practice and future clinical trials, and (5) the role of cytotoxic chemotherapy. A pre-congress questionnaire was undertaken with the consensus development committee members to help understand the current practice patterns for HCC in the Asia-Pacific region and to identify issues relating to optimal patient care and further clinical trials for which consensus needs to be developed. In this report, the results of the questionnaire are presented, and the pertinent issues identified by each consensus group for further discussion and consensus development are summarized.

UR - http://www.scopus.com/inward/record.url?scp=84945133625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945133625&partnerID=8YFLogxK

U2 - 10.1159/000367732

DO - 10.1159/000367732

M3 - Article

AN - SCOPUS:84945133625

VL - 4

SP - 96

EP - 105

JO - Liver Cancer

JF - Liver Cancer

SN - 2235-1795

IS - 2

ER -